Zucca, E.

Davies, A. J.; Zucca, E.; Ceriani, L.; Kryachok, I.; Ciccone, G.; Botto, B.; Balzarotti, M.; Tucci, A.; Rusconi, C.; Usai, S. V.; Pennese, E.; Arcaini, L.; Dabrowska‐Iwanicka, A.; Ferreri, A. J. M.; Merli, F.; Zhao, W.; Hodgson, D.; Rigacci, L.; Cellini, C.; Stelitano, C.; ... (2023). A RANDOMIZED TRIAL OF OBSERVATION VERSUS RADIOTHERAPY IN PRIMARY MEDIASTINAL B‐CELL LYMPHOMA PATIENTS WITH COMPLETE METABOLIC RESPONSE AFTER STANDARD IMMUNOCHEMOTHERAPY. Hematological oncology, 41(S2), pp. 48-50. Wiley 10.1002/hon.3163_19

Martinelli, G.; Ryan, G.; Seymour, J. F.; Nassi, L.; Steffanoni, S.; Alietti, A.; Calabrese, L.; Pruneri, G.; Santoro, L.; Kuper-Hommel, M.; Tsang, R.; Zinzani, P. L.; Taghian, A.; Zucca, E.; Cavalli, F. (2009). Primary follicular and marginal-zone lymphoma of the breast: clinical features, prognostic factors and outcome: a study by the International Extranodal Lymphoma Study Group. Annals of oncology, 20(12), pp. 1993-1999. Oxford University Press 10.1093/annonc/mdp238

Ryan, G.; Martinelli, G.; Kuper-Hommel, M.; Tsang, R.; Pruneri, G.; Yuen, K.; Roos, D.; Lennard, A.; Devizzi, L.; Crabb, S.; Hossfeld, D.; Pratt, G.; Dell'Olio, M.; Choo, S. P.; Bociek, R. G.; Radford, J.; Lade, S.; Gianni, A. M.; Zucca, E.; Cavalli, F.; ... (2007). Primary diffuse large B-cell lymphoma of the breast: prognostic factors and outcomes of a study by the International Extranodal Lymphoma Study Group. Annals of oncology, 19(2), pp. 233-241. Oxford University Press 10.1093/annonc/mdm471

Ferreri, A. J. M.; Blay, J.-Y.; Reni, M.; Pasini, F.; Gubkin, A.; Tirelli, U.; Calderoni, A.; Zucca, E.; Cortelazzo, S.; Chassagne, C.; Tinguely, M.; Borisch, B.; Berger, F.; Ponzoni, M.; Cavalli, F. (2002). Relevance of intraocular involvement in the management of primary central nervous system lymphomas. Annals of oncology, 13(4), pp. 531-538. Oxford University Press 10.1093/annonc/mdf080

Betticher, D. C.; Zucca, E.; Von Rohr, A.; Egger, T.; Radford, J. A.; Ambrosetti, A.; Bürki, K.; Rufener, B.; Hsu Schmitz, S. F.; Cerny, Thomas (1996). 2-Chlorodeoxyadenosine (2-CDA) therapy in previously untreated patients with follicular stage III–IV non-Hodgkin's lymphoma. Annals of oncology, 7(8), pp. 793-799. Oxford University Press 10.1093/oxfordjournals.annonc.a010757